November 6, 2006
Encore Medical Corporation closes on a merger agreement with a company newly formed and controlled by Blackstone Capital Partners V L.P. in a going private transaction.
On November 3, Encore Medical Corporation closed on a definitive merger agreement with a company newly formed and controlled by Blackstone Capital Partners V L.P. in a going private transaction valued at $870 million. Willkie’s Executive Compensation and Employee Benefits Department represented members of Encore’s Senior Management Team in the transaction. Encore develops, manufactures and distributes a comprehensive range of surgical reconstructive implant products, and orthopedic devices used for rehabilitation, pain management and physical therapy. The deal was handled by partner Stephen Lindo and associates David Rubinsky, Matthew Rizzo and Jordan Messinger.